ADNI: A review of papers published since its inception to 2013

Mon, Aug 12, 2013


“The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is an ongoing, longitudinal, multicenter study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimer’s disease (AD). The study aimed to enroll 400 subjects with early mild cognitive impairment (MCI), 200 subjects with early AD, and 200 normal control subjects; $67 million funding was provided by both the public and private sectors, including the National Institute on Aging, 13 pharmaceutical companies, and 2 foundations that provided support through the Foundation for the National Institutes of Health. This article reviews all papers published since the inception of the initiative and summarizes the results…”

Authors: Michael W. Weiner, Dallas P. Veitch, Paul S. Aisen, Laurel A. Beckett, Nigel J. Cairns, Robert C. Green, Danielle Harvey, Clifford R. Jack, William Jagust, Enchi Liu, John C. Morris, Ronald C. Petersen, Andrew J. Saykin, Mark E. Schmidt, Leslie Shaw, Li Shen, Judith A. Siuciak, Holly Soares, Arthur W. Toga, John Q. Trojanowski, Alzheimer’s Disease Neuroimaging Initiative

More Publications News

This post was written by: - who has written 40 posts on ADNI.

Comments are closed.

Search ADNI News:

Annual Archives